Dunst J - Search Results

1

Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment.

Krug D, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Piroth MD, Sedlmayer F, Souchon R, Wenz F, Sauer R; Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Krug D, et al. Among authors: dunst j. Strahlenther Onkol. 2018 Sep;194(9):797-805. doi: 10.1007/s00066-018-1329-8. Epub 2018 Jul 4. Strahlenther Onkol. 2018. PMID: 29974132 Review. English.

2

Radiochemotherapy for T1G3 bladder cancer.

Dunst J, Rödel C, Diestelhorst A, Heynemann H, Schrott KM, Sauer R. Dunst J, et al. Front Radiat Ther Oncol. 2002;36:151-8. doi: 10.1159/000061338. Front Radiat Ther Oncol. 2002. PMID: 11842745 Review. No abstract available.

3

Oxygenation measurements in head and neck cancers during hyperbaric oxygenation.

Becker A, Kuhnt T, Liedtke H, Krivokuca A, Bloching M, Dunst J. Becker A, et al. Among authors: dunst j. Strahlenther Onkol. 2002 Feb;178(2):105-8. doi: 10.1007/s00066-002-0892-0. Strahlenther Onkol. 2002. PMID: 11942033

4

Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil.

Rödel C, Grabenbauer GG, Kühn R, Zörcher T, Papadopoulos T, Dunst J, Schrott KM, Sauer R. Rödel C, et al. Among authors: dunst j. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1303-9. doi: 10.1016/s0360-3016(01)02771-7. Int J Radiat Oncol Biol Phys. 2002. PMID: 11955743

5

Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results.

Rödel C, Grabenbauer GG, Kühn R, Papadopoulos T, Dunst J, Meyer M, Schrott KM, Sauer R. Rödel C, et al. Among authors: dunst j. J Clin Oncol. 2002 Jul 15;20(14):3061-71. doi: 10.1200/JCO.2002.11.027. J Clin Oncol. 2002. PMID: 12118019

6

Phase I study of oral uracil and Tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancer.

Schiebe ME, Reese T, Wenz F, Schmidberger H, Engenhart-Cabillic R, Dunst J, Hess CF, Hoffmann W. Schiebe ME, et al. Among authors: dunst j. Anticancer Drugs. 2002 Nov;13(10):1005-9. doi: 10.1097/00001813-200211000-00004. Anticancer Drugs. 2002. PMID: 12439334 Clinical Trial.

7

Residual chromosomal damage after radiochemotherapy with and without amifostine detected by 24-color FISH.

Kuechler A, Dreidax M, Pigorsch SU, Liehr T, Claussen U, Wendt TG, Dunst J. Kuechler A, et al. Among authors: dunst j. Strahlenther Onkol. 2003 Jul;179(7):493-8. doi: 10.1007/s00066-003-1095-z. Strahlenther Onkol. 2003. PMID: 12835887 Clinical Trial.

8

Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia.

Vaupel P, Dunst J, Engert A, Fandrey J, Feyer P, Freund M, Jelkmann W. Vaupel P, et al. Among authors: dunst j. Onkologie. 2005 Apr;28(4):216-21. doi: 10.1159/000084033. Epub 2005 Mar 31. Onkologie. 2005. PMID: 15840971

9

[Prognostic factors after surgery and adjuvant radiotherapy in cervical cancers. A retrospective analysis of 298 patients after surgery and adjuvant radiotherapy].

Hänsgen G, Richter K, Gerlach R, Kuhnt T, Dunst J. Hänsgen G, et al. Among authors: dunst j. Strahlenther Onkol. 2005 May;181(5):285-92. doi: 10.1007/s00066-005-1281-2. Strahlenther Onkol. 2005. PMID: 15900424 German.

10

Organ-sparing treatment in muscle-invasive bladder cancer.

Dunst J, Diestelhorst A, Kühn R, Müller AC, Scholz HJ, Fornara P. Dunst J, et al. Strahlenther Onkol. 2005 Oct;181(10):632-7. doi: 10.1007/s00066-005-1416-5. Strahlenther Onkol. 2005. PMID: 16220401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

440 results

Search Page

Filters